Myocarditis in hypertrophic cardiomyopathy patients presenting acute clinical deterioration

被引:50
作者
Frustaci, Andrea
Verardo, Romina
Caldarulo, Marina
Acconcia, Maria Cristina
Russo, Matteo A.
Chimenti, Cristina
机构
[1] Univ Roma La Sapienza, Heart & Great Vessels Attilio Reale Dept, I-00100 Rome, Italy
[2] Natl Inst Infect Dis L Spallanzani, Mol & Cellular Cardiol Lab, Rome, Italy
[3] Univ Roma La Sapienza, Pathol & Expt Med Dept, Rome, Italy
[4] IRCCS San Raffaele Pisana, Rome, Italy
关键词
hypertrophic cardiomyopathy; myocarditis; viruses; arrhythmia; heart failure;
D O I
10.1093/eurheartj/ehl525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim We sought to determine whether myocarditis can be a major cause of acute electrical instability or clinical deterioration in HCM patients. Methods and results A total of 119 HCM patients (69 M/50F, mean age 41 +/- 8), 42 with acute clinical deterioration and 77 clinically stable, underwent cardiac catheterization with left ventricular endomyocardial biopsy and gene analysis of major sarcomeric proteins. Endomyocardial tissue was processed for histology, immunohistochemistry, and polymerase chain reaction for the most common cardiotropic viruses. Controls were surgical samples from 50 patients with mitral stenosis. All 119 patients showed histological findings suggestive of HCM. In addition, CD45RO+ lymphocytes (>= 14/mm(2)) with focal necrosis of the adjacent severely hypertrophied and often disorganized myocytes, consistent with an overlapping active myocarditis, were observed in 28 of 42 unstable and none of 77 stable HCM patients. A viral genome was detected in 14 of 28 patients with myocarditis and in none of HCM patients without and in none of controls. No correlation between sarcomeric protein gene mutations and HCM clinical profile was observed. Conclusion Myocarditis, often viral, represents a common cause of acute clinical deterioration in HCM. Its recognition can potentially affect disease prognosis and treatment.
引用
收藏
页码:733 / 740
页数:8
相关论文
共 24 条
[1]   A mechanic with a bad valve: blood-culture-negative endocarditis [J].
Albrich, WC ;
Kraft, C ;
Fisk, T ;
Albrecht, H .
LANCET INFECTIOUS DISEASES, 2004, 4 (12) :777-784
[2]  
Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3
[3]   Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy [J].
Badorff, C ;
Lee, GH ;
Lamphear, BJ ;
Martone, ME ;
Campbell, KP ;
Rhoads, RE ;
Knowlton, KU .
NATURE MEDICINE, 1999, 5 (03) :320-326
[4]   The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy [J].
Bowles, NE ;
Ni, JY ;
Marcus, F ;
Towbin, JA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) :892-895
[5]   Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy [J].
Cecchi, F ;
Olivotto, I ;
Gistri, R ;
Lorenzoni, R ;
Chiriatti, G ;
Camici, PG .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (11) :1027-1035
[6]   Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies [J].
Chien, KR .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (02) :175-178
[7]   Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy [J].
Chimenti, C ;
Pieroni, M ;
Morgante, E ;
Antuzzi, D ;
Russo, A ;
Russo, MA ;
Maseri, A ;
Frustaci, A .
CIRCULATION, 2004, 110 (09) :1047-1053
[8]   Inflammatory left ventricular microaneurysms as a cause of apparently idiopathic ventricular tachyarrhythmias [J].
Chimenti, C ;
Calabrese, F ;
Thiene, G ;
Pieroni, M ;
Maseri, A ;
Frustaci, A .
CIRCULATION, 2001, 104 (02) :168-173
[9]   Hypertrophic cardiomyopathy [J].
Elliott, P ;
McKenna, WJ .
LANCET, 2004, 363 (9424) :1881-1891
[10]   Immunosuppressive therapy for active lymphocytic myocarditis - Virological and immunologic profile of responders versus nonresponders [J].
Frustaci, A ;
Chimenti, C ;
Calabrese, F ;
Pieroni, M ;
Thiene, G ;
Maseri, A .
CIRCULATION, 2003, 107 (06) :857-863